Cocrystal Pharma Stock Filter Stocks by Fundamentals
| COCP Stock | USD 1.48 0.08 5.13% |
Cocrystal Pharma fundamentals help investors to digest information that contributes to Cocrystal Pharma's financial success or failures. It also enables traders to predict the movement of Cocrystal Stock. The fundamental analysis module provides a way to measure Cocrystal Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cocrystal Pharma stock.
Cocrystal | Shares Owned by Insiders |
Cocrystal Pharma Institutional Holders
Institutional Holdings refers to the ownership stake in Cocrystal Pharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cocrystal Pharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cocrystal Pharma's value.| Shares | Bank Of America Corp | 2024-12-31 | 9 K | Ubs Group Ag | 2024-12-31 | 6.1 K | Tower Research Capital Llc | 2024-12-31 | 830 | Northwestern Mutual Wealth Management Co | 2024-12-31 | 817 | Clean Yield Group Inc | 2024-12-31 | 418 | Jpmorgan Chase & Co | 2024-12-31 | 259 | Mccormack Advisors International | 2024-12-31 | 237 | Nvwm, Llc | 2024-12-31 | 84.0 | Royal Bank Of Canada | 2024-12-31 | 51.0 | Vanguard Group Inc | 2024-12-31 | 275.7 K | Renaissance Technologies Corp | 2024-12-31 | 125.8 K |
Cocrystal Fundamentals
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.52 | ||||
| Current Valuation | 4.93 M | ||||
| Shares Outstanding | 10.17 M | ||||
| Shares Owned By Insiders | 31.85 % | ||||
| Shares Owned By Institutions | 6.99 % | ||||
| Number Of Shares Shorted | 14.37 K | ||||
| Price To Earning | 193.33 X | ||||
| Price To Book | 1.27 X | ||||
| Price To Sales | 92.45 X | ||||
| Gross Profit | (14.77 M) | ||||
| EBITDA | (19.37 M) | ||||
| Net Income | (17.98 M) | ||||
| Cash And Equivalents | 51.03 M | ||||
| Cash Per Share | 6.28 X | ||||
| Total Debt | 1.85 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 18.34 X | ||||
| Book Value Per Share | 1.25 X | ||||
| Cash Flow From Operations | (14.67 M) | ||||
| Short Ratio | 0.55 X | ||||
| Earnings Per Share | (1.84) X | ||||
| Target Price | 8.33 | ||||
| Number Of Employees | 12 | ||||
| Beta | 2.35 | ||||
| Market Capitalization | 16.07 M | ||||
| Total Asset | 31.26 M | ||||
| Retained Earnings | (315.91 M) | ||||
| Working Capital | 25.83 M | ||||
| Current Asset | 6.75 M | ||||
| Current Liabilities | 3.15 M | ||||
| Net Asset | 31.26 M |
About Cocrystal Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cocrystal Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cocrystal Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cocrystal Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.